Rapid identification of Newcastle disease virus vaccine strains LaSota and B-1 by restriction site analysis of their matrix gene

E. Wehmann, J. Herczeg, A. Ballagi-Pordány, B. Lomniczi

Research output: Article

19 Citations (Scopus)

Abstract

A region constituting 88% of the matrix gene of Newcastle disease virus vaccine strains LaSota and B-1 was amplified by reverse transcription- polymerase chain reaction. Amplified products of LaSota and B-1 strains derived from vaccine serials of different companies were digested with restriction enzymes MboI and HinfI. Strain characteristic cleavage site maps were obtained that allowed for a reliable and rapid differentiation between strains LaSota and B-1.

Original languageEnglish
Pages (from-to)1430-1433
Number of pages4
JournalVaccine
Volume15
Issue number12-13
DOIs
Publication statusPublished - aug. 1 1997

ASJC Scopus subject areas

  • Molecular Medicine
  • Immunology and Microbiology(all)
  • veterinary(all)
  • Public Health, Environmental and Occupational Health
  • Infectious Diseases

Fingerprint Dive into the research topics of 'Rapid identification of Newcastle disease virus vaccine strains LaSota and B-1 by restriction site analysis of their matrix gene'. Together they form a unique fingerprint.

  • Cite this